Metformin represses the pathophysiology of AAA by suppressing the activation of PI3K/AKT/mTOR/autophagy pathway in ApoE−/− mice

Publisher Correction: Alpha-fetoprotein inhibits autophagy to promote malignant behaviour in hepatocellular carcinoma cells by activating PI3K/AKT/mTOR signalling

(2019) Shanshan Wang et al.   Cell Death & Disease

The Association of Biomarkers of Inflammation and Extracellular Matrix Degradation With the Risk of Abdominal Aortic Aneurysm: The ARIC Study

(2018) Weihong Tang et al.   ANGIOLOGY

Pharmacological Therapy of Abdominal Aortic Aneurysm: An Update

(2018) Yi-dong Wang et al.   Current Vascular Pharmacology

MiR-1290 promotes proliferation, migration, and invasion of glioma cells by targeting LHX6

(2018) Lei Yan et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Metformin prescription status and abdominal aortic aneurysm disease progression in the U.S. veteran population

(2018) Nathan K. Itoga et al.   JOURNAL OF VASCULAR SURGERY

Autophagy of macrophages is regulated by PI3k/Akt/mTOR signalling in the development of diabetic encephalopathy

(2018) Beiyun Wang et al.   Aging-US

Arctigenin shows preferential cytotoxicity to acidity-tolerant prostate carcinoma PC-3 cells through ROS-mediated mitochondrial damage and the inhibition of PI3K/Akt/mTOR pathway

(2018) Yoon-Jin Lee et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Post-translational modifications of Beclin 1 provide multiple strategies for autophagy regulation

(2018) Sandra M. Hill et al.   CELL DEATH AND DIFFERENTIATION

Tauroursodeoxycholic Acid Attenuates Angiotensin II Induced Abdominal Aortic Aneurysm Formation in Apolipoprotein E-deficient Mice by Inhibiting Endoplasmic Reticulum Stress

(2017) Y. Qin et al.   EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY

Association of Matrix Metalloproteinase Levels with Collagen Degradation in the Context of Abdominal Aortic Aneurysm

(2017) V. Klaus et al.   EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY

Metformin use and survival of lung cancer patients: Meta-analysis findings

(2017) J Zhao et al.   INDIAN JOURNAL OF CANCER

Metformin inhibits endothelial progenitor cell migration by decreasing matrix metalloproteinases, MMP-2 and MMP-9, via the AMPK/mTOR/autophagy pathway

(2017) Wen-Dong Li et al.   INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE

Metformin and thyroid disease

(2017) Xianghui Meng et al.   JOURNAL OF ENDOCRINOLOGY

Metformin in breast cancer

(2017) Conor A. Bradley   Nature Reviews Endocrinology

Risk of abdominal aortic aneurysm (AAA) among male and female relatives of AAA patients

(2017) Koen M van de Luijtgaarden et al.   VASCULAR MEDICINE

NLRP3 inflammasome activation contributes to VSMC phenotypic transformation and proliferation in hypertension

(2017) Hai-Jian Sun et al.   Cell Death & Disease

Metformin: a review of its potential indications

(2017) Yi-Wei Wang et al.   Drug Design Development and Therapy

Concurrent administration of trastuzumab and anthracyclines as adjuvant regimen for HER2-positive breast cancer: a randomised controlled trial

(2017) Songjie Shen et al.   Oncotarget

Metformin use and survival of lung cancer patients: Meta-analysis findings

(2017) J Zhao et al.   INDIAN JOURNAL OF CANCER

Inverse relationship between Alzheimer’s disease and cancer, and other factors contributing to Alzheimer’s disease: a systematic review

(2016) Ovais Shafi   BMC Neurology

Vascular Smooth Muscle Cells in Atherosclerosis

(2016) Martin R. Bennett et al.   CIRCULATION RESEARCH

Metformin for Prevention and Treatment of Colon Cancer: A Reappraisal of Experimental and Clinical Data

(2016) Vladimir N. Anisimov   CURRENT DRUG TARGETS

Biomechanical Indices for Rupture Risk Estimation in Abdominal Aortic Aneurysms

(2016) Eva L. Leemans et al.   JOURNAL OF ENDOVASCULAR THERAPY

Update on the prevention of death from ruptured abdominal aortic aneurysm

(2016) Jo Jacomelli et al.   JOURNAL OF MEDICAL SCREENING

Abdominal aortic aneurysm

(2015) Frank M. Davis et al.   CURRENT OPINION IN CARDIOLOGY

Ginsenoside Rb1 attenuates angiotensin II-induced abdominal aortic aneurysm through inactivation of the JNK and p38 signaling pathways

(2015) Xiao-Jing Zhang et al.   VASCULAR PHARMACOLOGY

Chemokine (C-X-C Motif) Receptor 4 Blockade by AMD3100 Inhibits Experimental Abdominal Aortic Aneurysm Expansion Through Anti-Inflammatory Effects

(2014) Stéphanie Michineau et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Selective Inhibition of PI3K/Akt/mTOR Signaling Pathway Regulates Autophagy of Macrophage and Vulnerability of Atherosclerotic Plaque

(2014) Chungang Zhai et al.   PLoS One

Potential role of vascular smooth muscle cell-like progenitor cell therapy in the suppression of experimental abdominal aortic aneurysms

(2013) Hyung Sub Park et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Zoledronate attenuates angiotensin II-induced abdominal aortic aneurysm through inactivation of Rho/ROCK-dependent JNK and NF-κB pathway

(2013) Shih-Hung Tsai et al.   CARDIOVASCULAR RESEARCH

A CD31-derived peptide prevents angiotensin II-induced atherosclerosis progression and aneurysm formation

(2012) Giulia Fornasa et al.   CARDIOVASCULAR RESEARCH